Morgan Stanley Call 280 AMG 20.12.../ DE000MB0BQ72 /
2024-03-28 8:38:36 PM | Chg.-0.05 | Bid10:00:30 PM | Ask10:00:30 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.95EUR | -1.67% | - Bid Size: - |
- Ask Size: - |
AMGEN INC. DL-... | 280.00 - | 2024-12-20 | Call |
GlobeNewswire
03-25
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate ...
GlobeNewswire
03-25
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Director...
GlobeNewswire
03-20
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
GlobeNewswire
03-18
NVIDIA Healthcare Launches Generative AI Microservices to Advance Drug Discovery, MedTech and Digita...
GlobeNewswire
03-18
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D...
GlobeNewswire
03-18
CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Col...
GlobeNewswire
03-15
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire
03-14
Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
GlobeNewswire
03-12
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program...
GlobeNewswire
03-07
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Busine...
GlobeNewswire
03-07
Oxford BioTherapeutics Announces Launch of Enhanced Discovery Platform, OGAP®-Verify, at World ADC C...
GlobeNewswire
03-06
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business...